Our CEO-CSO and COO attended the last edition of Biofit in Strasbourg on December 2nd-3rd, co-organized again this year with MedFIT.

DRUGABILIS presence on the AFSSI booth enabled numerous interactions with TTO/SATT reps, biotech team-leaders and complementary preclinical R&D service providers, sharing with them details about our pharmaceutical drugability service offer for early R&D during very valuable B2B meetings.

We want to thank the organizers and the attendees… and we’ll be glad to attend Biofit edition next year!

2025 edition key figures >

Back to All drugability services >

Any specific issue you want to discuss?